<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23764" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Iritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gurnani</surname>
            <given-names>Bharat</given-names>
          </name>
          <aff>Gomabai Netralaya and Research Centre</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kim</surname>
            <given-names>Jessica</given-names>
          </name>
          <aff>Louisiana State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahabadi</surname>
            <given-names>Navid</given-names>
          </name>
          <aff>A.T. Still University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Edens</surname>
            <given-names>Mary Ann</given-names>
          </name>
          <aff>Louisiana State University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bharat Gurnani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jessica Kim declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Navid Mahabadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mary Ann Edens declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23764.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Anterior uveitis (iritis) is the inflammation of the anterior chamber and the iris. Uveitis is often idiopathic, but it may be triggered by genetic, immune, traumatic, or infectious mechanisms. The symptoms include redness, sensitivity to light, and pain. Slit-lamp examination reveals cells in the anterior chamber. Proper evaluation is necessary for recurrent anterior uveitis. The management options include topical steroids and cycloplegics. With appropriate treatment and follow-up, it has a good prognosis. This activity highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of iritis.</p></list-item><list-item><p>Review the steps for evaluating iritis.</p></list-item><list-item><p>Summarize the treatment options of iritis.</p></list-item><list-item><p>Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by iritis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23764&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23764">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23764.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The International Uveitis Study Group (IUSG) recommended the anatomical classification of uveitis into anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis.<xref ref-type="bibr" rid="article-23764.r1">[1]</xref>&#x000a0;The&#x000a0;Standardization of Uveitis Nomenclature (SUN) working group endorsed the same anatomical classification.<xref ref-type="bibr" rid="article-23764.r2">[2]</xref>&#x000a0;This anatomical location is based on the actual site of inflammation and is not affected by the presence or absence of structural complications, including cystoid macular edema.<xref ref-type="bibr" rid="article-23764.r2">[2]</xref>&#x000a0;The primary location of inflammation in anterior uveitis is the anterior chamber (AC).<xref ref-type="bibr" rid="article-23764.r2">[2]</xref>&#x000a0;The&#x000a0;anterior uveitis includes three entities, namely iritis, iridocyclitis, and anterior cyclitis.<xref ref-type="bibr" rid="article-23764.r2">[2]</xref> The inflammation of the iris is termed as iritis, and that involving&#x000a0;the anterior part of the ciliary body is known as anterior cyclitis.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref>&#x000a0;</p>
        <p>When both of these are involved, it is called&#x000a0;iridocyclitis.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref>&#x000a0;Anterior uveitis is the most common form of uveitis.<xref ref-type="bibr" rid="article-23764.r4">[4]</xref>&#x000a0;The most common clinical presentation is acute anterior uveitis (AAU).<xref ref-type="bibr" rid="article-23764.r5">[5]</xref> The most common etiologies include HLA-B27 and idiopathic.<xref ref-type="bibr" rid="article-23764.r5">[5]</xref> It is difficult to pinpoint the etiology in some cases, and it may be secondary to the cross-reactivity of microbial antigens in genetically predisposed patients.<xref ref-type="bibr" rid="article-23764.r6">[6]</xref>&#x000a0;The etiology of AAU can be varied, ranging from viral infections, bacterial infections, trauma, lens-related inflammation, keratitis, and scleritis. It can exist alone as AAU or in conjuction with intermediate uveitis, posterior uveitis, or panuveitis. Chronic anterior uveitis (CAU) is usually bilateral secondary to an underlying systemic pathology and is less common than AAU.<xref ref-type="bibr" rid="article-23764.r7">[7]</xref>&#x000a0;The prognosis is typically good in most idiopathic and HLAB27- related AAU cases, provided management is adequate.<xref ref-type="bibr" rid="article-23764.r8">[8]</xref>&#x000a0;Outcomes are more variable in CAU and cases with an underlying ocular or systemic disorder.<xref ref-type="bibr" rid="article-23764.r5">[5]</xref></p>
      </sec>
      <sec id="article-23764.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most cases of iritis are idiopathic, while 20% are due to blunt trauma.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
        <p>Nontraumatic iritis often is associated with HLA- B27 systemic diseases, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Juvenile Rheumatoid Arthritis (JRA)<xref ref-type="bibr" rid="article-23764.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Ulcerative Colitis<xref ref-type="bibr" rid="article-23764.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Reiter syndrome<xref ref-type="bibr" rid="article-23764.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Sarcoidosis<xref ref-type="bibr" rid="article-23764.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Behcet's disease<xref ref-type="bibr" rid="article-23764.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Tubulointerstitial Nephritis and Uveitis (TINU)<xref ref-type="bibr" rid="article-23764.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Systemic Lupus Erythematosus (SLE)<xref ref-type="bibr" rid="article-23764.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Multiple Sclerosis<xref ref-type="bibr" rid="article-23764.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Ankylosing Spondylitis<xref ref-type="bibr" rid="article-23764.r17">[17]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Infectious Causes&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tuberculosis<xref ref-type="bibr" rid="article-23764.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Chlamydia<xref ref-type="bibr" rid="article-23764.r19">[19]</xref></p>
          </list-item>
          <list-item>
            <p>Lyme's disease<xref ref-type="bibr" rid="article-23764.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Herpes Simplex<xref ref-type="bibr" rid="article-23764.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Toxoplasmosis<xref ref-type="bibr" rid="article-23764.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Varicella-Zoster virus (herpes zoster ophthalmicus or shingles)<xref ref-type="bibr" rid="article-23764.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Syphilis.<xref ref-type="bibr" rid="article-23764.r24">[24]</xref><xref ref-type="bibr" rid="article-23764.r5">[5]</xref><xref ref-type="bibr" rid="article-23764.r25">[25]</xref>.&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Other Causes&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Drug-induced<xref ref-type="bibr" rid="article-23764.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Masquerade syndromes like lymphoma, leukemia, malignant melanoma<xref ref-type="bibr" rid="article-23764.r27">[27]</xref></p>
          </list-item>
          <list-item>
            <p>Juvenile Xanthogranuloma<xref ref-type="bibr" rid="article-23764.r28">[28]</xref></p>
          </list-item>
        </list>
        <p>After Idiopathic variety, HLA-B27 associated uveitic ranks as the second commonest cause of anterior uveitis.<xref ref-type="bibr" rid="article-23764.r6">[6]</xref> It is responsible for 40-70% of anterior uveitis cases in varied geographical regions. It is more common in males than females.<xref ref-type="bibr" rid="article-23764.r29">[29]</xref>&#x000a0;</p>
        <p>
<bold>The Various HLA-B27 Associated Conditions with Ocular Involvement are Listed Below</bold>
<xref ref-type="bibr" rid="article-23764.r30">[30]</xref>
</p>
        <table-wrap id="article-23764.table0" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p>S. No</p>
</td>
                <td rowspan="1" colspan="1">
<p>HLA-B27 associated condition</p>
</td>
                <td rowspan="1" colspan="1">
<p>Ocular features</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>1</p>
</td>
                <td rowspan="1" colspan="1">
<p>Ankylosing Spondylitis</p>
</td>
                <td rowspan="1" colspan="1">
<p>Acute anterior uveitis, conjunctivitis, keratitis</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>2</p>
</td>
                <td rowspan="1" colspan="1">
<p>Reiter's disease (reactive arthritis)</p>
</td>
                <td rowspan="1" colspan="1">
<p>Anterior uveitis, intermediate uveitis, posterior uveitis, keratitis, conjunctivitis, papillitis, scleritis, cataract</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>3</p>
</td>
                <td rowspan="1" colspan="1">
<p>Juvenile spondyloarthropathy</p>
</td>
                <td rowspan="1" colspan="1">
<p>Anterior uveitis</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>4</p>
</td>
                <td rowspan="1" colspan="1">
<p>Psoriatic arthritis</p>
</td>
                <td rowspan="1" colspan="1">
<p>Anterior uveitis, keratitis, dry eyes, conjunctivitis, panuveitis, scleritis, cataract, papillitis, pigmentary retinopathy</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>5</p>
</td>
                <td rowspan="1" colspan="1">
<p>Inflammatory bowel disease</p>
</td>
                <td rowspan="1" colspan="1">
<p>Conjunctivitis, episcleritis, scleritis anterior uveitis, cataract, vitritis retinal vasculitis, &#x000a0;peripheral ulcerative keratitis</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>6</p>
</td>
                <td rowspan="1" colspan="1">
<p>Undifferentiated spondyloarthropathies</p>
</td>
                <td rowspan="1" colspan="1">
<p>Acute anterior uveitis or chronic anterior uveitis, vitritis, retinal vasculitis</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Rodriguez et al., from their large-scale analysis from a tertiary eye care center, listed the prevalence of various etiologies in all the anatomic forms of uveitis.<xref ref-type="bibr" rid="article-23764.r31">[31]</xref></p>
        <p>The most common conditions were:</p>
        <list list-type="bullet">
          <list-item>
            <p>Idiopathic</p>
          </list-item>
          <list-item>
            <p>Seronegative spondyloarthropathies</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>JRA</p>
          </list-item>
          <list-item>
            <p>SLE</p>
          </list-item>
          <list-item>
            <p>Behcet's</p>
          </list-item>
          <list-item>
            <p>HIV</p>
          </list-item>
        </list>
        <p>Ankylosing spondylitis, Inflammatory bowel disease, psoriatic arthritis, and Reiter's syndrome are grouped under seronegative spondyloarthropathies.<xref ref-type="bibr" rid="article-23764.r32">[32]</xref> As per Rodriguez et al., the most common form was anterior uveitis, with the most common etiology being idiopathic followed by seronegative arthropathy, JRA, herpes, sarcoidosis, SLE, and rheumatoid arthritis. The next was posterior uveitis, with common etiologies being toxoplasmosis, idiopathic, CMV, SLE, and sarcoidosis.<xref ref-type="bibr" rid="article-23764.r33">[33]</xref></p>
      </sec>
      <sec id="article-23764.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Anterior uveitis is the most common form of uveitis (occurring every 12 per 100 000 cases).<xref ref-type="bibr" rid="article-23764.r5">[5]</xref> It predominantly occurs in young and middle-aged people. In western countries, 50% to 70% of all uveitis cases are classified as anterior uveitis. Uveitis is responsible for 10% of legal blindness in the USA, and it accounts for approximately 30,000 new patients with blindness every year.<xref ref-type="bibr" rid="article-23764.r34">[34]</xref> The study from northern California on the epidemiology of uveitis revealed an incidence of 52.4 per 100000 persons per year and a prevalence of 115.3 per 100000 persons.<xref ref-type="bibr" rid="article-23764.r35">[35]</xref></p>
        <p>The maximum incidence and prevalence were seen in elderly patients above 65 years and lowest in the pediatric age group. Women had a higher prevalence than men.<xref ref-type="bibr" rid="article-23764.r35">[35]</xref> The study from Affairs Medical Centre, Northwest Pacific, reported an incidence of 25.6 cases per 100000 persons and a prevalence of 69 per 100000 persons.<xref ref-type="bibr" rid="article-23764.r36">[36]</xref> The study in the elderly population from the care survey medicare cohort revealed an incidence of uveitis ranging from 302-424 per 100000 persons per year and an average of 340.9 per 100000.<xref ref-type="bibr" rid="article-23764.r37">[37]</xref> The mean incidence of uveitis was 243.6 per 100000. The reported incidence of posterior uveitis was 76.6 per 100000, and panuveitis incidence was 41.7 per 100000.<xref ref-type="bibr" rid="article-23764.r37">[37]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23764.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Eye pain is thought to be due to irritation of the ciliary nerves and ciliary muscle spasms. Photophobia is caused by irritation of the trigeminal nerve from the ciliary spasm.<xref ref-type="bibr" rid="article-23764.r38">[38]</xref> Increased permeability of blood vessels in the anterior chamber allows proteinaceous transudate ("flare") and WBCs ("cells"), the characteristic 'flare and cells' seen with the slit lamp.<xref ref-type="bibr" rid="article-23764.r39">[39]</xref> In traumatic uveitis, there can be microbial contamination and retention of necrotic debris at the site of trauma, resulting from a florid inflammatory response in the anterior segment of the eye. In infectious uveitis, the pathophysiological mechanism is immune-mediated destruction of foreign antigens that may cause damage to the uveal tissue, vessels, and cells.<xref ref-type="bibr" rid="article-23764.r40">[40]</xref> There is immune complex deposition inside the uveal tract in autoimmune uveitic conditions, a form of hypersensitivity reaction.<xref ref-type="bibr" rid="article-23764.r41">[41]</xref><xref ref-type="bibr" rid="article-23764.r39">[39]</xref></p>
        <p>Uveal inflammation behaves similarly to inflammation in other body tissues, i.e., having a vascular and cellular response. But due to excessive vascularity and looseness of uveal tissue, there is heightened vascular response. Pathophysiologically, the uveal inflammation is subdivided into purulent (suppurative) and nonpurulent (non-suppurative) types.<xref ref-type="bibr" rid="article-23764.r41">[41]</xref></p>
        <p>
<bold>Wood&#x02019;s Classification of Non-Suppurative Inflammation</bold>
<xref ref-type="bibr" rid="article-23764.r42">[42]</xref>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Non-granulomatous</p>
          </list-item>
          <list-item>
            <p>Granulomatous</p>
          </list-item>
        </list>
        <p>
<bold>Suppurative Uveitis</bold>
</p>
        <p>It results from exogenous infections from pyogenic microorganisms. It is a part of the spectrum of endophthalmitis or panophthalmitis and is caused by Staphylococci, Streptococci, Pseudomonas, Pneumococcus. In suppurative inflammation, there occur outpouring of purulent exudates and an increase in polymorphonuclear cells. The uveal tissue increases in size, becomes thickened, and demonstrates necrosis and pus formation&#x000a0;in the cavities.<xref ref-type="bibr" rid="article-23764.r43">[43]</xref></p>
        <p>
<bold>Non-granulomatous Uveitis</bold>
</p>
        <p>In non-granulomatous (NG) uveitis, diffuse inflammation is characterized by dilatation and increase in permeability of vasculature, blood-aqueous barrier breakdown, increase in exudates, increased infiltration by lymphocytes, plasma cells and, macrophages.<xref ref-type="bibr" rid="article-23764.r44">[44]</xref> The iris becomes edematous, muddy in color, and waterlogging occurs. As a result, there occur loss of crypts and furrows. Further, there is iridoplegia; the pupil becomes small and sluggish due to the engorgement of iris vessels. The infiltration of exudates and lymphocytes manifests as cells and flare in the anterior chamber and KPs at the back of endothelium.<xref ref-type="bibr" rid="article-23764.r45">[45]</xref> The exudates can also be seen in the posterior segment and manifest as posterior synechiae, where the posterior iris adheres to the anterior lens capsule. Sometimes exudates may occupy the ciliary body and result in a cyclitic membrane. In the healing phase, atrophy of the iris is evident, and there may be areas of necrosis. Further destructive changes manifest as necrosis, gliotic and fibrotic areas, resulting in adhesions, scar formation, and eventual destruction of uveal tissue.<xref ref-type="bibr" rid="article-23764.r46">[46]</xref></p>
        <p>
<bold>Granulomatous Uveitis</bold>
</p>
        <p>In granulomatous uveitis, there is increased infiltration by lymphocytes, plasma cells, epithelioid cells, and giant cells resulting in nodule formation. The nodules may be seen at the pupillary border, such as Koeppe's nodules) and nodules may be seen at the back of the cornea as mutton fat KP's. This may be followed by necrosis, gliotic and fibrotic areas which result in adhesions, scar formation, and eventual destruction of uveal tissue.<xref ref-type="bibr" rid="article-23764.r5">[5]</xref></p>
      </sec>
      <sec id="article-23764.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histopathological findings in uveitis vary with etiology.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Lens induced uveitis </bold>- Macrophages, acute and chronic inflammatory cells<xref ref-type="bibr" rid="article-23764.r47">[47]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Parasitic uveitis&#x000a0;</bold>- Eosinophils, polymorphonuclear neutrophils, and parasites occasionally<xref ref-type="bibr" rid="article-23764.r48">[48]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Masquerade syndrome&#x000a0;</bold>- Cellular infiltrates in retinoblastoma, leukemia, etc. and malignant cells<xref ref-type="bibr" rid="article-23764.r49">[49]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Phacoanaphylactic uveitis -</bold> Epithelioid cells, polymorphonuclear neutrophils, and giant cells<xref ref-type="bibr" rid="article-23764.r50">[50]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Uveitis</bold>- Predominant lymphocytic infiltrate<xref ref-type="bibr" rid="article-23764.r51">[51]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Late-onset Endophthalmitis -&#x000a0;</bold>Propionibacterium on gram stain, culture plating, or PCR<xref ref-type="bibr" rid="article-23764.r52">[52]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Endophthalmitis -&#x000a0;</bold>Acute and chronic inflammatory cell infiltrate along with offending microorganism<xref ref-type="bibr" rid="article-23764.r53">[53]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Lymphomas (large cell) -&#x000a0;</bold>Cells with pleomorphism, oval or circular nuclei, and scanty cytoplasm. There is an occasional predominance of micronuclei<xref ref-type="bibr" rid="article-23764.r54">[54]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23764.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Classification</bold>
</p>
        <p>The anatomical classification of uveitis is proposed by the Standardization of Uveitis Nomenclature (SUN) Working Group.</p>
        <p>
<bold>Anatomical</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Anterior- </bold>Involving the iris and ciliary body<xref ref-type="bibr" rid="article-23764.r55">[55]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Intermediate- </bold>Involving vitreous and pars plana<xref ref-type="bibr" rid="article-23764.r56">[56]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Posterior- </bold>Involving retina and choroid<xref ref-type="bibr" rid="article-23764.r57">[57]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Panuveitis- </bold>Anterior, intermediate and posterior<xref ref-type="bibr" rid="article-23764.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>
<bold>The Etiological Classification of Uveitis is Proposed by the International Uveitis Study Group (IUSG)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Infectious</bold>- Viral, bacterial, parasitic, Lyme disease, etc.&#x000a0;<xref ref-type="bibr" rid="article-23764.r58">[58]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Non-infectious</bold>- Idiopathic or associated with systemic diseases<xref ref-type="bibr" rid="article-23764.r45">[45]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Masquerade</bold>- &#x000a0;Neoplastic and non-neoplastic<xref ref-type="bibr" rid="article-23764.r59">[59]</xref></p>
          </list-item>
        </list>
        <p>
<bold>SUN Working Group Proposed the Classification Based on the Timing of Inflammation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Timing of onset</bold>- Insidious or sudden<xref ref-type="bibr" rid="article-23764.r60">[60]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Duration of inflammation</bold>- Limited (less than or equal to 3 months ) or persistent<xref ref-type="bibr" rid="article-23764.r61">[61]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Clinical Activity</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Acute</bold>- Insidious or sudden</p>
          </list-item>
          <list-item>
            <p><bold>Chronic</bold>- Persistent with relapse within three months after stopping the treatment</p>
          </list-item>
          <list-item>
            <p><bold>Recurrent</bold>- Repeated episodes with an in-between inactive period&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Remission</bold>- No active episode for three months or more<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Anterior Uveitis</bold>
</p>
        <p>
<bold>Acute</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Pain, redness, photophobia, tearing, and decreased vision with pain developing over a few hours or days except in trauma cases.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Chronic&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Blurred vision, mild redness, and little pain or photophobia except during an acute episode.<xref ref-type="bibr" rid="article-23764.r62">[62]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Slit Lamp Evaluation in Uveitis Patients</bold>
</p>
        <p>Circumciliary congestion or circumcorneal congestion (injection) gives the appearance of a purple hue due to involvement in conjunctival plexus and deeper vessels. It's a sign of AAU and may not be seen in CAU.</p>
        <p>Pupillary miosis is due to iridoplegia and sphincter spasms, which lead to the formation of posterior synechiae.</p>
        <p>Anterior chamber cells are estimated by SUN grading with the help of a 1x1 mm slit beam under adequate lighting and magnification. The cells and flare indicate inflammatory activity inside the anterior chamber. The cells and flare should be assessed before pupillary dilatation as dilatation invites pigment shedding into the aqueous. The cells can also be observed in the vitreous phase.<xref ref-type="bibr" rid="article-23764.r63">[63]</xref></p>
        <p>
<bold>SUN Grading of Cells in Anterior Chamber (1 mm x 1 mm Slit Beam)</bold>
<bold>&#x000a0;</bold>
</p>
        <table-wrap id="article-23764.table1" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Grade</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Cells in the field</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>1</p>
</td>
                <td rowspan="1" colspan="1">
<p>0</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x0003c; 1</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>2</p>
</td>
                <td rowspan="1" colspan="1">
<p>0.5+</p>
</td>
                <td rowspan="1" colspan="1">
<p>1-5</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>3</p>
</td>
                <td rowspan="1" colspan="1">
<p>1+</p>
</td>
                <td rowspan="1" colspan="1">
<p>6-15</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>4</p>
</td>
                <td rowspan="1" colspan="1">
<p>2+</p>
</td>
                <td rowspan="1" colspan="1">
<p>16-25</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>5</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+</p>
</td>
                <td rowspan="1" colspan="1">
<p>26-50</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>6</p>
</td>
                <td rowspan="1" colspan="1">
<p>4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>&#x0003e;50</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>An anterior chamber or aqueous flare is the turbid appearance of the aqueous in the anterior chamber due to the proteins secondary to the breakdown of the blood-aqueous barrier. In children with JIA-associated CAU, flare is taken as the level of inflammatory activity more than cells and indicates complications in the long term. Flare is graded on a slit lamp by assessing the iris and lens details. Laser flare photometry is another modality for objective grading.<xref ref-type="bibr" rid="article-23764.r63">[63]</xref></p>
        <p>
<bold>SUN Classification of Flare in the Anterior Chamber </bold>
</p>
        <table-wrap id="article-23764.table2" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Grade</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Description</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>1</p>
</td>
                <td rowspan="1" colspan="1">
<p>0</p>
</td>
                <td rowspan="1" colspan="1">
<p>None</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>2</p>
</td>
                <td rowspan="1" colspan="1">
<p>1+</p>
</td>
                <td rowspan="1" colspan="1">
<p>Faint</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>3</p>
</td>
                <td rowspan="1" colspan="1">
<p>2+</p>
</td>
                <td rowspan="1" colspan="1">
<p>Moderate- Clear iris and lens details</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>4</p>
</td>
                <td rowspan="1" colspan="1">
<p>3+</p>
</td>
                <td rowspan="1" colspan="1">
<p>Marked- Hazy iris and lens details</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>5</p>
</td>
                <td rowspan="1" colspan="1">
<p>4+</p>
</td>
                <td rowspan="1" colspan="1">
<p>Intense- Plastic or fibrin aqueous</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Hypopyon is the presence of whitish purulent exudative material in the anterior chamber. It is composed of inflammatory material, and form appears as a horizontal level that is gravity-dependent. It is common in HLA B27 associated uveitis. The hypopyon is immobile due to high fibrin content, making it difficult to absorb. Behcet's disease patients have a characteristically mobile hypopyon due to low fibrin content.<xref ref-type="bibr" rid="article-23764.r64">[64]</xref>&#x000a0;Hypopyon is inflammatory cells deposited in the anterior chamber and is composed of leucocytes.<xref ref-type="bibr" rid="article-23764.r64">[64]</xref> It is measured with the help of a slit lamp micrometer. The shape, color, and consistency of hypopyon are indicators of etiology. It can be mobile or fixed. To test the mobility of hypopyon, the patient is asked to lie down supine for 10 minutes. Then after 10 minutes, the level of hypopyon is tested. In the case of fixed hypopyon, there is no movement, but in the case of mobile hypopyon, the level or height is changed.<xref ref-type="bibr" rid="article-23764.r65">[65]</xref></p>
        <p>
<bold>&#x000a0;Various Types of Hypopyon in Different Condition</bold>
</p>
        <table-wrap id="article-23764.table3" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>S. No</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Hypopyon characteristic</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Diagnosis/etiology</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>1</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Sterile</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>&#x000a0;Behcet's disease</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>2</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Mobile</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Bacterial keratitis</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>3</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Fixed/ Immobile</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Fungal keratitis</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>4</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Central</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Pneumococcal keratitis</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>5</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Haemorrhagic</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Pneumococcus, herpetic keratitis, trauma</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>6</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Other causes</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Endophthalmitis, ranibizumab, JIA, histiocytosis, Leukemia, laser iridotomy, lens-induced, HLA-B27 uveitis, leptospirosis, phacolysis</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Keratic precipitates (KPs) are inflammatory cellular deposits at the back of the cornea (endothelium). The cellular aggregates include lymphocytes, plasma cells, and macrophages. Epithelial cells and giant cells are also common in KPs. The KPs are seen inferior one-third of the cornea in a triangular pattern with the apex pointing upwards (Arlt's triangle). The KPs are distributed in Arlt's triangle due to aqueous convection currents and the effect of gravity. In contrast, they can be seen diffusely distributed in Fuch's heterochromic iridocyclitis (FHIC) and viral uveitis (stellate KPs). The morphological appearance of KPs indicates the type of uveitis, like small KPs in non-granulomatous (NG) uveitis and large in granulomatous uveitis. Large glistening greasy KPs are seen as granulomatous uveitis and are called mutton fat KPs. Once the acute episode resolves, KP usually disappears. Pigmented KPs can be observed (NG variety). The granulomatous KPs may also become pigmented and are classically described as the ground-glass appearance of KPs. Sometime before the appearance of KP's diffuse pigment deposition is seen at the back of the cornea called endothelial dusting.<xref ref-type="bibr" rid="article-23764.r66">[66]</xref>&#x000a0;</p>
        <table-wrap id="article-23764.table4" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Characteristic</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Type of KP</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Fresh</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Old</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>1</p>
</td>
                <td rowspan="1" colspan="1">
<p>Colour</p>
</td>
                <td rowspan="1" colspan="1">
<p>White</p>
</td>
                <td rowspan="1" colspan="1">
<p>Pigmented</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>2</p>
</td>
                <td rowspan="1" colspan="1">
<p>Shape</p>
</td>
                <td rowspan="1" colspan="1">
<p>Circular/ Round</p>
</td>
                <td rowspan="1" colspan="1">
<p>Flat</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>3</p>
</td>
                <td rowspan="1" colspan="1">
<p>Hydration</p>
</td>
                <td rowspan="1" colspan="1">
<p>Fully hydrated</p>
</td>
                <td rowspan="1" colspan="1">
<p>Dehydrated</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>4</p>
</td>
                <td rowspan="1" colspan="1">
<p>Edges</p>
</td>
                <td rowspan="1" colspan="1">
<p>Smooth</p>
</td>
                <td rowspan="1" colspan="1">
<p>Crenated</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The fibrinous membrane is a common entity in AAU and is seen in the anterior chamber.</p>
        <p>Iris atrophy is another clinical sign of uveitic sequelae. Diffuse iris atrophy is observed in FHIC, and a patchy or sectoral pattern&#x000a0;appears in&#x000a0;herpetic uveitis. Sectoral iris atrophy can be seen more in herpes zoster uveitis, although both sectoral and diffuse patterns can be observed in both herpes simplex and zoster uveitis.<xref ref-type="bibr" rid="article-23764.r67">[67]</xref></p>
        <p>Iris nodules are observable in both NG and the granulomatous variety.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Koeppe's nodules</bold>&#x000a0;- These are present at the pupillary margin or the location of posterior synechiae. These are ectodermal nodules usually white and may be pigmented. They can be seen in granulomatous as well as non granulomatous uveitis.</p>
          </list-item>
          <list-item>
            <p><bold>Busacca's nodules - </bold>These involve the iris stroma and are predominantly seen in granulomatous variety.</p>
          </list-item>
          <list-item>
            <p><bold>Roseolae</bold>&#x000a0;- These are yellow nodules are seen in Syphilis, resulting from dilatation of iris vessels.</p>
          </list-item>
          <list-item>
            <p><bold>Berlin nodules</bold>&#x000a0;- These are seen in angles in cases with sarcoidosis.</p>
          </list-item>
          <list-item>
            <p><bold>Iris pearls</bold>&#x000a0;- These are observed in lepromatous uveitis.</p>
          </list-item>
          <list-item>
            <p><bold> Russell bodies -&#x000a0; </bold>These, also called iris crystals, are seen in FHIC and rare cases of chronic uveitis. They are thought to result from immunoglobin deposits.<xref ref-type="bibr" rid="article-23764.r68">[68]</xref></p>
          </list-item>
        </list>
        <p>Posterior synechiae (PS) are another essential clinical finding in uveitic cases. They result from adhesion of the pupil margin to the anterior capsule secondary to uncontrolled inflammation. PS can be seen at the site of the Koeppe nodule. All cases should be instilled with a cycloplegic agent like atropine or homatropine to prevent PS formation.<xref ref-type="bibr" rid="article-23764.r69">[69]</xref></p>
        <p>
<bold>Types of Posterior Synechiae</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Segmental&#x000a0;</bold>- They are adhesions of the iris at some points over the lens</p>
          </list-item>
          <list-item>
            <p><bold>Annular (ring)</bold> - They are 360-degree adhesion of the iris to the anterior lens capsule</p>
          </list-item>
          <list-item>
            <p><bold>Total</bold>- These are plastered posterior surface of iris to the lens</p>
          </list-item>
          <list-item>
            <p><bold>Broad</bold>- They are seen in tubercular uveitis</p>
          </list-item>
          <list-item>
            <p><bold>Filiform</bold>-They are seen in non-tubercular uveitis</p>
          </list-item>
          <list-item>
            <p><bold>Seculusio pupillae</bold>- When synechiae cover the 360-degree pupil and prevent migration of aqueous from posterior to the anterior chamber</p>
          </list-item>
          <list-item>
            <p><bold>Occlusio pupillae</bold>- Formation of membrane over the lens surface</p>
          </list-item>
          <list-item>
            <p><bold>Festooned pupil</bold>- When synechiae are localized, and on dilatation, the pupil takes an irregular shape&#x000a0;</p>
          </list-item>
        </list>
        <p>Heterochromic iris is the difference in the color of the iris between the two eyes. Heterochromia is seen in FHIC.<xref ref-type="bibr" rid="article-23764.r70">[70]</xref></p>
        <p>Neovascularization of the iris (rubeosis iris) can result from chronic inflammation. The vascularization seems to be less as compared to posterior segment pathologies. FHIC shows abnormal iris vessels but does not result in synechial angle closure. Iris's new vessels are also seen in posterior uveitis. Sometimes it becomes difficult to differentiate between new and normal iris vessels (pseudo-rubeosis of the iris). The differentiating point is new vessels show irregular branching in contrast to normal vessels, which are radial. Fluorescein angiography is used to assess the leakage from new vessels.<xref ref-type="bibr" rid="article-23764.r71">[71]</xref></p>
        <p>Fundus evaluation is mandatory in each case to rule out masquerades like malignant melanoma, retinal detachment, cystoid macular edema, and other posterior segment complications.&#x000a0;</p>
        <p>
<bold>Difference between Granulomatous and Non-Granulomatous Uveitis</bold>
</p>
        <table-wrap id="article-23764.table5" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Characteristic</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Type of Uveitis</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Granulomatous</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Non-Granulomatous</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>1.</p>
</td>
                <td rowspan="1" colspan="1">
<p>Time of onset</p>
</td>
                <td rowspan="1" colspan="1">
<p>Insidious</p>
</td>
                <td rowspan="1" colspan="1">
<p>Acute</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>2</p>
</td>
                <td rowspan="1" colspan="1">
<p>Pain severity</p>
</td>
                <td rowspan="1" colspan="1">
<p>Mild</p>
</td>
                <td rowspan="1" colspan="1">
<p>Marked</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>3</p>
</td>
                <td rowspan="1" colspan="1">
<p>Photophobia</p>
</td>
                <td rowspan="1" colspan="1">
<p>Mild</p>
</td>
                <td rowspan="1" colspan="1">
<p>Marked</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>4</p>
</td>
                <td rowspan="1" colspan="1">
<p>Congestion</p>
</td>
                <td rowspan="1" colspan="1">
<p>Minimal</p>
</td>
                <td rowspan="1" colspan="1">
<p>Marked</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>5</p>
</td>
                <td rowspan="1" colspan="1">
<p>Keratic precipitates</p>
</td>
                <td rowspan="1" colspan="1">
<p>Large- Mutton fat</p>
</td>
                <td rowspan="1" colspan="1">
<p>Small</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>6</p>
</td>
                <td rowspan="1" colspan="1">
<p>Anterior chamber flare</p>
</td>
                <td rowspan="1" colspan="1">
<p>Mild</p>
</td>
                <td rowspan="1" colspan="1">
<p>Marked</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>7</p>
</td>
                <td rowspan="1" colspan="1">
<p>Iris nodules</p>
</td>
                <td rowspan="1" colspan="1">
<p>Present</p>
</td>
                <td rowspan="1" colspan="1">
<p>Absent</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>8</p>
</td>
                <td rowspan="1" colspan="1">
<p>Posterior synechiae</p>
</td>
                <td rowspan="1" colspan="1">
<p>Thick and broad</p>
</td>
                <td rowspan="1" colspan="1">
<p>Thin and flat</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>9</p>
</td>
                <td rowspan="1" colspan="1">
<p>Posterior segment</p>
</td>
                <td rowspan="1" colspan="1">
<p>Patchy involvement</p>
</td>
                <td rowspan="1" colspan="1">
<p>Diffuse involvement</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Difference between Acute and Chronic Uveitis</bold>
</p>
        <table-wrap id="article-23764.table6" position="float" orientation="portrait">
          <table>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>S. No</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Characteristic</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Type of Uveitis</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p><bold>Acute</bold></p>
</td>
                <td rowspan="1" colspan="1">
<p><bold>Chronic</bold></p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>1.</p>
</td>
                <td rowspan="1" colspan="1">
<p>Time of onset</p>
</td>
                <td rowspan="1" colspan="1">
<p>Sudden</p>
</td>
                <td rowspan="1" colspan="1">
<p>Acute</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>2</p>
</td>
                <td rowspan="1" colspan="1">
<p>Symptoms</p>
</td>
                <td rowspan="1" colspan="1">
<p>Pain, redness, photophobia</p>
</td>
                <td rowspan="1" colspan="1">
<p>Asymptomatic, reduced vision and floaters</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>3</p>
</td>
                <td rowspan="1" colspan="1">
<p>Start date</p>
</td>
                <td rowspan="1" colspan="1">
<p>Definite</p>
</td>
                <td rowspan="1" colspan="1">
<p>Not definitive</p>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
<p>4</p>
</td>
                <td rowspan="1" colspan="1">
<p>Resolution</p>
</td>
                <td rowspan="1" colspan="1">
<p>Self-resolving mostly</p>
</td>
                <td rowspan="1" colspan="1">
<p>Long duration</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-23764.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Since iritis involves anterior uveitis per se, the evaluation and treatment are focussed on anterior uveitis only. Further laboratory tests or imaging may be required if systemic involvement or infectious disease is suspected to be the underlying cause.<xref ref-type="bibr" rid="article-23764.r72">[72]</xref><xref ref-type="bibr" rid="article-23764.r73">[73]</xref><xref ref-type="bibr" rid="article-23764.r74">[74]</xref><xref ref-type="bibr" rid="article-23764.r75">[75]</xref>&#x000a0;In most uveitic cases, the investigations are normal, and no underlying etiology can be discerned. Tailored made investigations are needed in each patient to pinpoint the etiology based on the clinical signs. In some cases, the etiology is evident on the clinical examination, like uveitis in the case of endophthalmitis post-surgery. Most patients also need systemic evaluation and careful review by an internist.<xref ref-type="bibr" rid="article-23764.r76">[76]</xref></p>
        <p>
<bold>Visual Acuity</bold>
</p>
        <p>Visual acuity depends on the extent of inflammatory activity and associated complications. It is generally minimally reduced in AAU. Snellen's uncorrected and best-corrected visual acuity should be documented in each patient. The improvement in visual acuity is also an indicator of resolution of uveitis and reduction in inflammation.<xref ref-type="bibr" rid="article-23764.r77">[77]</xref></p>
        <p>
<bold>Intraocular Pressure</bold>
</p>
        <p>Intraocular pressure (IOP) can be raised in uveitic cases. The reduction in IOP is due to ciliary shutdown or reduction in aqueous secretion from the ciliary epithelium. The raised IOP can be due to angle closure, trabeculitis, steroid-induced, and other causes. The IOP can be measured by noncontact tonometry, ICARE tonometer, or Goldman applanation tonometer and should be documented on each visit.<xref ref-type="bibr" rid="article-23764.r78">[78]</xref></p>
        <p>
<bold>Cases of Uveitis where Investigations are Not Mandatory</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The first episode of unilateral mild NG AAU with no previous ocular or systemic history</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Classical clinical signs of a specific etiology for which investigation will not be helpful like FHIC</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>When the systemic signs and symptoms are indicative of a particular etiology associated with uveitis like sarcoidosis, tuberculosis, multiple sclerosis, etc.&#x000a0;<xref ref-type="bibr" rid="article-23764.r79">[79]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Cases of Uveitis where Investigations Will be Helpful</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Bilateral cases of AAU</p>
          </list-item>
          <list-item>
            <p>Severe cases AAU</p>
          </list-item>
          <list-item>
            <p>Recurrent cases of AAU</p>
          </list-item>
          <list-item>
            <p>Chronic A.U. resistance to treatment</p>
          </list-item>
          <list-item>
            <p>Granulomatous AU</p>
          </list-item>
          <list-item>
            <p>AAU associated with I.U. or posterior uveitis or panuveitis cases</p>
          </list-item>
          <list-item>
            <p>Ocular and systemic signs indication underlying pathology<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>Further laboratory tests or imaging may be required if systemic involvement or infectious disease is suspected to be the underlying cause.<xref ref-type="bibr" rid="article-23764.r72">[72]</xref><xref ref-type="bibr" rid="article-23764.r73">[73]</xref><xref ref-type="bibr" rid="article-23764.r74">[74]</xref><xref ref-type="bibr" rid="article-23764.r75">[75]</xref></p>
        <p>
<bold>Imaging</bold>
</p>
        <p>Chest radiography may be considered if sarcoidosis or tuberculosis is the underlying cause of uveitis. In granulomatous uveitis cases, a high index of suspicion should be kept to rule out these treatable systemic conditions as well as syphilis. X-ray of the sacroiliac joint reveals bamboo spine and sacroiliitis in cases with ankylosing spondylitis and other seronegative spondyloarthropathies.<xref ref-type="bibr" rid="article-23764.r80">[80]</xref></p>
        <p>
<bold>Ocular Imaging </bold>
</p>
        <p>
<bold>B Scan Ultrasound</bold>
</p>
        <p>A B scan should be performed in the fundus that is not visualized due to small pupil, anterior chamber reaction, fibrinous membrane, or vitreous haze.<xref ref-type="bibr" rid="article-23764.r81">[81]</xref></p>
        <p>
<bold>Optical Coherence Tomography</bold>
</p>
        <p>It's a handy tool to rule out cystoid macular edema and epiretinal membrane and look for cells and flare.<xref ref-type="bibr" rid="article-23764.r82">[82]</xref></p>
        <p>
<bold>Fundus Fluorescein Angiography </bold>
</p>
        <p>This is an essential investigation in chronic uveitis cases to rule out posterior segment pathology like vasculitis macular ischemia delineate capillary non-perfusion areas and white dot syndrome spectrum.<xref ref-type="bibr" rid="article-23764.r83">[83]</xref></p>
        <p>
<bold>Fundus Autofluorescence </bold>
</p>
        <p>Fundus autofluorescence (FAF) is essential in posterior segment pathologies to rule out white dot syndromes and severe inflammatory conditions.</p>
        <p>
<bold>Indocyanine Green Angiography </bold>
</p>
        <p>Indocyanine green angiography (ICGA) is needed in cases with uveitis-associated choroidal pathology.<xref ref-type="bibr" rid="article-23764.r84">[84]</xref></p>
        <p>
<bold>Ultrasound Biomicroscopy</bold>
</p>
        <p>Ultrasound biomicroscopy (UBM) is helpful to rule out hypotony (ciliary shutdown), choroidal effusion, cyclodialysis cleft, and cyclitic membrane.<xref ref-type="bibr" rid="article-23764.r85">[85]</xref></p>
        <p>
<bold>Laboratory Workup</bold>
</p>
        <p>Laboratory workup is usually not&#x000a0;necessary. In mild unilateral non-granulomatous uveitis with trauma or no evidence of systemic disease, laboratory studies are unlikely to be helpful. If there is the presence of bilateral granulomatous or recurrent uveitis, a workup is indicated.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref> Tests to consider include:</p>
        <p>
<bold>Human Leucocyte Antigen tissue typing (HLA-B27)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>HLA- B27 testing should be done in any patient with recurrent A.U. or chronic N.G. A.U. The various HLA types and their associations are detailed below.</p>
          </list-item>
          <list-item>
            <p>HLA B27- Recurrent AAU</p>
          </list-item>
          <list-item>
            <p>HLA-B51 and HLA B5- Behcet's disease</p>
          </list-item>
          <list-item>
            <p>HLA-A29- Birdshot retinochoroiditis</p>
          </list-item>
          <list-item>
            <p>HLA-DR4- Sympathetic Ophthalmia and Vogt-Koyanagi-Harada disease</p>
          </list-item>
          <list-item>
            <p>HLA-B7 and HLA-DR- Presumed Ocular Histoplasmosis Syndrome<xref ref-type="bibr" rid="article-23764.r86">[86]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Syphilis Serology</bold>
</p>
        <p>The various test implicated in syphilis is treponemal antibody tests such as ELISA- enzyme-linked immunosorbent assay, which has high specificity and sensitivity but takes approximately three months to show positivity. Anti-cardiolipin antibody tests (non-specific) like venereal research laboratory test (VDRL) and rapid plasma regain (RPR) demonstrate positive results in the acute phase of the disease and help to monitor the disease and treatment. The patients having features of ocular syphilis&#x000a0;should be referred to an internist to rule out sexually transmitted syphilis.<xref ref-type="bibr" rid="article-23764.r87">[87]</xref></p>
        <p>
<bold>Angiotensin-Converting Enzyme</bold>
</p>
        <p>This is a non-specific test to rule out the cause of N.G. A.U. such as sarcoidosis, tuberculosis, and Hansen disease. Serum levels of ACE are elevated in approximately 80% of patients with sarcoidosis but come down to normal levels during remission.<xref ref-type="bibr" rid="article-23764.r88">[88]</xref></p>
        <p>
<bold>Serum Lysozyme Assay</bold>
</p>
        <p>Lysozyme, an enzyme, is found in neutrophils and tear secretion. It has antibacterial properties and can cause bacterial cell wall breakdown. This test has comparatively less sensitivity and specificity than serum ACE in diagnosing sarcoidosis, but the combined test may prove more beneficial.<xref ref-type="bibr" rid="article-23764.r76">[76]</xref></p>
        <p>
<bold>Complete Blood Count</bold>
</p>
        <p>A raised leucocyte count is indicative of infective may be a hematological malignancy. Eosinophils are raised in parasitic causes of uveitis.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
        <p>
<bold>Inflammatory Markers</bold>
</p>
        <p>C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and acute phase reactants may be elevated in systemic inflammatory disorders.<xref ref-type="bibr" rid="article-23764.r89">[89]</xref></p>
        <p>
<bold>Lyme Disease Serology</bold>
</p>
        <p>Disease-specific serology is essential in endemic areas, including serology for other infections like brucellosis and leptospirosis.<xref ref-type="bibr" rid="article-23764.r90">[90]</xref></p>
        <p>
<bold>Antinuclear Antibody</bold>
</p>
        <p>Antinuclear antibody (ANA) is the most important marker for juvenile idiopathic arthritis in children. ANA positivity is an indicator of CAU.<xref ref-type="bibr" rid="article-23764.r91">[91]</xref></p>
        <p>
<bold>Antineutrophil Cytoplasmic Antibody</bold>
</p>
        <p>Antineutrophil cytoplasmic antibody (ANCA) is valuable for anterior uveitis associated with scleritis. It is a valuable marker for Wegner granulomatosis (c-ANCA) and Polyarteritis Nodosa (PAN) {p-ANCA}.<xref ref-type="bibr" rid="article-23764.r92">[92]</xref></p>
        <p>
<bold>Interferon-Gamma Release Assay</bold>
</p>
        <p>Interferon-gamma Release Assay such as QuantiFERON-TB Gold for diagnosis of tuberculosis.<xref ref-type="bibr" rid="article-23764.r93">[93]</xref></p>
        <p>
<bold>HIV Serology</bold>
</p>
        <p>HIV tridot test for suspected patients with immunosuppression.<xref ref-type="bibr" rid="article-23764.r94">[94]</xref></p>
        <p>
<bold>Anterior Chamber Tap</bold>
</p>
        <p>An anterior chamber aqueous tap can be performed, and a sample can be sent for a polymerase chain reaction in cases of suspected viral uveitis like herpes, varicella, and rubella. PCR will also distinguish Propionibacterium acne infection in chronic uveitis in pseudophakic eyes.<xref ref-type="bibr" rid="article-23764.r95">[95]</xref></p>
        <p>
<bold>Iris Biopsy</bold>
</p>
        <p>Iris biopsy is another critical investigation but is rarely done nowadays.<xref ref-type="bibr" rid="article-23764.r96">[96]</xref></p>
        <p>
<bold>Vitreous Biopsy</bold>
</p>
        <p>In the case of associated posterior segment involvement, especially in the case of suspected endophthalmitis.<xref ref-type="bibr" rid="article-23764.r97">[97]</xref></p>
        <p>
<bold>Conjunctival Biopsy</bold>
</p>
        <p>In case of suspected granulomas or infiltrative lesions, a conjunctival biopsy is indicated.<xref ref-type="bibr" rid="article-23764.r98">[98]</xref></p>
        <p>
<bold>Physician Referral</bold>
</p>
        <p>To rule out systemic pathologies, timely referral to an internist is essential to pinpoint the etiology&#x02014;for example, HRCT in pulmonary tuberculosis and MRI in cases of multiple sclerosis.</p>
      </sec>
      <sec id="article-23764.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is primarily aimed&#x000a0;at&#x000a0;reducing inflammation and pain and preventing complications. First-line treatment involves topical cycloplegics (dilate the pupil, prevent the ciliary body and pupillary spasm) and topical steroids (decrease inflammation). The patient should be referred to&#x000a0;an ophthalmologist within 24 to 48 hours. The review frequency is decided based on the clinical presentation and degree of inflammatory activity. Those with severe inflammation need review within a day or two, and those with mild AAU may be seen after a week or so.</p>
        <list list-type="bullet">
          <list-item>
            <p>Sustained-release corticosteroid vitreous implants (fluocinolone acetonide, dexamethasone) are available to treat inflammation-induced cases of panuveitis, intermediate uveitis, and posterior uveitis.</p>
          </list-item>
          <list-item>
            <p>Corticosteroids should be initiated only in conjunction with the approval of an ophthalmologist because uveitis is a diagnosis of exclusion.</p>
          </list-item>
          <list-item>
            <p>Steroids can have adverse effects, such as causing intraocular pressure, cataract formation, steroid-induced glaucoma, and the development of&#x000a0;herpes keratitis.</p>
          </list-item>
          <list-item>
            <p>Potassium-sparing drugs should be used&#x000a0;when chronic steroid use is required to control inflammation. Approximately half of the patients with uveitis need treatment beyond corticosteroid treatment to prevent vision loss.<xref ref-type="bibr" rid="article-23764.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Topical Steroids</bold>
</p>
        <p>Corticosteroids decrease inflammation. Treatment should only be initiated after consultation with an ophthalmologist. Prednisolone 1% or dexamethasone 0.1% are potent steroids and are the first treatment choice for uveitis. They work by decreasing inflammation by reversing increased capillary permeability and suppressing the migration of polymorphonuclear leukocytes.</p>
        <p>The other drugs used for iritis management are difluprednate 0.05% (lower frequency), prednisolone 0.5%, loteprednol etabonate 0.5% and 0.2%, betamethasone, fluorometholone, and rimexolone (moderate to low potency). Steroid regimen can be altered based on the response and intraocular pressure elevation. Betamethasone ointment can be used at bedtime. The steroid regimen varies according to the degree of inflammation, starting from an hourly regimen for three days to every two hours for three days, then 6/5/4/3/2/1 times one week each. The treatment is usually stopped after 6&#x000a0;to 8 weeks. Timely and regular follow-up is mandated in each case. In CAU cases, the target is the full resolution of inflammation. Low-grade persistent inflammation can result in a higher incidence of complications which can be reduced with regular and timely steroids instillation. Steroids can act as a bilateral sword, resulting in elevated IOP (steroid response), cataract, glaucoma, keratitis, and corneal melt.<xref ref-type="bibr" rid="article-23764.r99">[99]</xref></p>
        <p>
<bold>Cycloplegics</bold>
</p>
        <p>Cycloplegics block nerve impulses to the ciliary muscles and pupillary sphincter to decrease photophobia and pain. They are implicated in AAU and CAU exacerbations. These help to break down the already formed posterior synechiae prevent the formation of new synechiae.</p>
        <p>
<bold>Homatropine</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Induces cycloplegia in 30&#x000a0;to 90 minutes.</p>
          </list-item>
          <list-item>
            <p>Induces mydriasis in 10&#x000a0;to&#x000a0;30 minutes.</p>
          </list-item>
          <list-item>
            <p>Effects last 10&#x000a0;to&#x000a0;48 hours for cycloplegia and 6 to 96 hours for mydriasis, but the duration may be less if severe anterior chamber reaction.</p>
          </list-item>
          <list-item>
            <p>Homatropine is an agent of choice for uveitis.</p>
          </list-item>
        </list>
        <p>
<bold>Cyclopentolate 0.5% to 2%</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Induces cycloplegia in 25&#x000a0;to&#x000a0;75 minutes.</p>
          </list-item>
          <list-item>
            <p>Induces mydriasis in 30&#x000a0;to&#x000a0;60 minutes.</p>
          </list-item>
          <list-item>
            <p>Effects usually last one day.</p>
          </list-item>
          <list-item>
            <p>Less attractive for treating uveitis than homatropine.</p>
          </list-item>
        </list>
        <p>The other cycloplegics available are atropine which has a long duration of action of 7-10 days. In AAU, 2.5% or 10% phenylephrine can also break posterior synechiae. Bedtime administration of the drug should be promoted to avoid difficulties with accommodation during the daytime. Atropine has been known to cause toxic side effects like seizures amblyopia in children, and extra precautions should be taken while administering drugs to children.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
        <p>
<bold>Mydricaine</bold>
</p>
        <p>Mydricaine is a preparation of 0.3 ml containing 0.12 mg adrenaline, 1mg atropine, and 6 mg procaine. Adrenaline and atropine break the posterior synechiae and procaine to improve comfort. The drug combination is given as a subconjunctival injection. Another installation method is cotton pledget dipped in Mydricaine and kept for 5 minutes in the superior and inferior fornices for 5 minutes. Mydricaine number 1 is used pediatric version, and mydricaine number 2 is used in adults. The side effect reported with Mydricaine is transient sinus tachycardia.<xref ref-type="bibr" rid="article-23764.r100">[100]</xref></p>
        <p>
<bold>Tissue Plasminogen Activator </bold>
</p>
        <p>In severe fibrinous anterior uveitis cases, 12.5&#x000a0;to 25 ug of tissue plasminogen activator is injected in the anterior chamber in 0.1 ml solution with a 30 G needle under topical anesthesia. This will dissolve the fibrin membrane and break down the posterior synechiae.<xref ref-type="bibr" rid="article-23764.r101">[101]</xref></p>
        <p>
<bold>Subconjunctival Steroids</bold>
</p>
        <p>Betamethasone sodium phosphate and acetate combination can be given for severe A.U. and patients with poor compliance subconjunctivally.<xref ref-type="bibr" rid="article-23764.r102">[102]</xref></p>
        <p>
<bold>Subtenons Injection of Steroids</bold>
</p>
        <p>Posterior sub tenons injection of methylprednisolone or triamcinolone acetonide can be given in cases with aggressive posterior segment inflammation and in patients with anterior uveitis having cystoid macular edema a complication. They can be instilled as an OPD procedure or given during the surgery to supplement the systemic steroids. The onset of action is four weeks, and the maximum duration is around three months. Varied complications have been reported like secondary glaucoma, globe perforation, subconjunctival hemorrhage, cataract, retrobulbar hemorrhage, and ptosis.<xref ref-type="bibr" rid="article-23764.r103">[103]</xref></p>
        <p>
<bold>Intravitreal Steroids</bold>
</p>
        <p>Intravitreal triamcinolone acetonide (4 mg in 0.1 ml) is also implicated in cystoid macular edema after anterior uveitis, which is not responding to other therapy. The complications are similar to sub tenons administration except pseudohypopyon, exclusive to intravitreal steroids.<xref ref-type="bibr" rid="article-23764.r104">[104]</xref></p>
        <p>
<bold>Systemic Steroids</bold>
</p>
        <p>When the inflammation is severe and response to topical treatment is inadequate, oral prednisolone is indicated. They are given in tapering doses, and each case should monitor side effects.<xref ref-type="bibr" rid="article-23764.r102">[102]</xref></p>
        <p>
<bold>Non- Steroidal Anti- Inflammatory Drugs (NSAIDs)</bold>
</p>
        <p>Naproxen and tolmetin are implicated in CAU cases and can be used for the long term under physician observation.<xref ref-type="bibr" rid="article-23764.r99">[99]</xref></p>
        <p>
<bold>Antimetabolites</bold>
</p>
        <p>Methotrexate is implicated in CAU secondary to juvenile idiopathic arthritic in children when steroids fail to control the inflammation.<xref ref-type="bibr" rid="article-23764.r105">[105]</xref></p>
        <p>
<bold>Tumor Necrosis Factor Blockers</bold>
</p>
        <p>Infliximab or adalimumab may be&#x000a0;used as second-line treatment for patients with vision-threatening chronic uveitis caused by seronegative spondyloarthropathy.<xref ref-type="bibr" rid="article-23764.r106">[106]</xref></p>
      </sec>
      <sec id="article-23764.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses include</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute angle-closure glaucoma</p>
          </list-item>
          <list-item>
            <p>Conjunctivitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Subconjunctival hemorrhage</p>
          </list-item>
          <list-item>
            <p>Trauma</p>
          </list-item>
          <list-item>
            <p>Episcleritis</p>
          </list-item>
          <list-item>
            <p>Scleritis</p>
          </list-item>
          <list-item>
            <p>Dry eyes</p>
          </list-item>
          <list-item>
            <p>Pingueculitis</p>
          </list-item>
          <list-item>
            <p>Inflammed pterygium</p>
          </list-item>
          <list-item>
            <p>Corneal abrasion</p>
          </list-item>
          <list-item>
            <p>Corneal ulcer</p>
          </list-item>
          <list-item>
            <p>HSV keratitis</p>
          </list-item>
          <list-item>
            <p>Intraocular foreign body</p>
          </list-item>
          <list-item>
            <p>Scleritis</p>
          </list-item>
          <list-item>
            <p>Ulcerative keratitis</p>
          </list-item>
          <list-item>
            <p>Ultraviolet keratitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23764.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis is good with appropriate treatment. To have the best prognosis, follow-up care with an ophthalmologist within 24 hours is imperative. Monitoring should include repeat slit-lamp and intraocular pressure checks every few days. When the condition is stable, monitoring can be every 1&#x000a0;to 6 months. If not diagnosed and treated on time and neglected cases usually develop complications like cataract, glaucoma, retinal detachment, and macular edema, and the prognosis is guarded in these cases.<xref ref-type="bibr" rid="article-23764.r107">[107]</xref></p>
      </sec>
      <sec id="article-23764.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Corneal scar (keratouveitis)</p>
          </list-item>
          <list-item>
            <p>Band shaped keratopathy</p>
          </list-item>
          <list-item>
            <p>Hyphema</p>
          </list-item>
          <list-item>
            <p>Non-resolving hypopyon</p>
          </list-item>
          <list-item>
            <p>Iris atrophy</p>
          </list-item>
          <list-item>
            <p>Posterior synechiae</p>
          </list-item>
          <list-item>
            <p>Cataract (Inflammation related, steroid-induced)</p>
          </list-item>
          <list-item>
            <p>Secondary glaucoma (pupillary block, inflammation, or topical corticosteroid)</p>
          </list-item>
          <list-item>
            <p>Occlusio pupillae</p>
          </list-item>
          <list-item>
            <p>Festooned pupil</p>
          </list-item>
          <list-item>
            <p>Seclusio pupillae</p>
          </list-item>
          <list-item>
            <p>Cystoid macular edema</p>
          </list-item>
          <list-item>
            <p>Optic neuropathy</p>
          </list-item>
          <list-item>
            <p>Optic disc neovascularization</p>
          </list-item>
          <list-item>
            <p>Macular scar</p>
          </list-item>
          <list-item>
            <p>Hypotony</p>
          </list-item>
          <list-item>
            <p>Vitreous hemorrhage (associated intermediate, posterior, or panuveitis)</p>
          </list-item>
          <list-item>
            <p>Retinal detachment</p>
          </list-item>
          <list-item>
            <p>Endophthalmitis<xref ref-type="bibr" rid="article-23764.r53">[53]</xref></p>
          </list-item>
          <list-item>
            <p>Panophthalmitis</p>
          </list-item>
          <list-item>
            <p>Permanent blindness</p>
          </list-item>
          <list-item>
            <p>Strabismus<xref ref-type="bibr" rid="article-23764.r108">[108]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23764.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>In cases undergoing cataract surgery, postoperative care is required for complicated cataract of filtration surgery for non-resolving glaucoma or progressive glaucomatous changes. For patients undergoing cataract surgery, the usual regimen is topical steroids (1% prednisolone or 0.1% dexamethasone) or steroids and antibiotic combination (0.1% dexamethasone + 0.5% gatifloxacin) 6/5/4/3/2/1 times for one week each along with a cycloplegic like topical 5% homatropine or 1% atropine two times per day for 2&#x000a0;to 3 weeks.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
        <p>The patients should be regularly and closely followed to prevent any complications. In patients undergoing filtration surgery, the usual regimen is topical steroids &#x000a0;(prednisolone 1% or dexamethasone 0.1%) or steroids and antibiotic combination (dexamethasone 0.1% &#x000a0;+ gatifloxacin 0.5%) 8/7/6/5/4/3/2/1 times for one week each along with a cycloplegic like topical homatropine 5% &#x000a0;or atropine 1% two times per day for 2&#x000a0;to 3 weeks. These patients should be closely followed up to rule out complications like macular snuff out, hypotony, uncontrolled glaucoma and check for the normal functioning bleb.<xref ref-type="bibr" rid="article-23764.r109">[109]</xref> The patients requiring retinal detachment repair are also treated post-operatively with the same regimen as glaucoma patients. Two to three months later, these patients will require silicon oil removal. All these patients should also be closely followed up to rule out re-detachment and other complications of retinal surgery.<xref ref-type="bibr" rid="article-23764.r110">[110]</xref></p>
      </sec>
      <sec id="article-23764.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Any patient presenting to the clinic with pain, redness, and photophobia should be meticulously evaluated by an Ophthalmologist with suspicion of iritis. In the case of keratouveitis, the patient should be referred to a cornea specialist for higher opinion and management to rule out infective and autoimmune keratitis. Non-resolving iritis, endophthalmitis, or cases with diagnostic dilemmas must be evaluated by a retina and uvea specialist for expert opinion and further management. The patient with underlying systemic pathology leading to iritis and uveitis should be referred timely to an internist to pinpoint the etiology and targeted systemic treatment. Iritis with trabeculitis, angle-closure, or open-angle glaucoma should be managed with a glaucoma specialist. Patients with complicated cataracts requiring surgical intervention should be ideally operated on by a cataract and IOL surgeon for an excellent visual outcome.<xref ref-type="bibr" rid="article-23764.r3">[3]</xref></p>
      </sec>
      <sec id="article-23764.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with iritis should be explained about the ocular pathology the importance of regular and timely treatment and follow-up. The patient should be educated about the underlying systemic pathology associated with iritis and the critical role of the internist in treating the condition. The patients should also be explained about the complications related to iritis and the side effects of irregular and long-term use of steroids.</p>
      </sec>
      <sec id="article-23764.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Anterior uveitis can present as an isolated entity or associated intermediate and posterior uveitis. There can be a spillover of anterior segment inflammation into the vitreous or posterior segment. All patients should undergo extensive evaluation to pinpoint the etiology. The internists have a key role to play in the diagnosis and management of uveitic cases. If untreated, complications can include decreased visual acuity and/or blindness, glaucoma, cataracts,&#x000a0;and irregular pupil.<xref ref-type="bibr" rid="article-23764.r5">[5]</xref></p>
      </sec>
      <sec id="article-23764.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of a patient with iritis is interprofessional. Whenever a patient presents with eye pain, tearing, photophobia, vision loss, and red-eye in the absence of trauma, the patient must be referred to an ophthalmologist as soon as possible. The treatment of iritis primarily aims to reduce inflammation and pain and prevent complications. First-line treatment involves topical cycloplegics (dilate the pupil, prevent the ciliary body and pupillary spasm) and topical steroids (decrease inflammation). Depending on the cause, most patients respond well to treatment and retain full vision. However, at least 10&#x000a0;to 30% of patients may need treatment beyond steroids to prevent vision loss.<xref ref-type="bibr" rid="article-23764.r24">[24]</xref><xref ref-type="bibr" rid="article-23764.r111">[111]</xref>&#x000a0;[Level 5] Once discharged, the patient may follow up with the ophthalmic nurse, primary care provider, or ophthalmologist.<xref ref-type="bibr" rid="article-23764.r5">[5]</xref></p>
      </sec>
      <sec id="article-23764.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23764&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23764">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/iritis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23764">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23764/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23764">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-23764.s19">
        <fig id="article-23764.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Slit-lamp image of the patient of recurrent anterior uveitis depicting circumciliary congestion, corneal scarring, central band shaped keratopathy, hypopyon in anterior chamber and pseudophakia Contributed by Dr. Bharat Gurnani, MBBS, DNB, FCRS, FICO, MRCS Ed, MNAMS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1378341__hypopyon__uveitis_20180308_174701_DC4Image_L_001" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-23764.s20">
        <fig id="article-23764.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Slit- lamp image of the patient with recurrent uveitis depicting mild circumciliary congestion, nebular corneal scarring, few areas of iris atrophy along with a complicated cataract Contributed by Dr. Bharat Gurnani, MBBS, DNB, FCRS, FICO, MRCS Ed, MNAMS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IRITIS__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-23764.s21">
        <title>References</title>
        <ref id="article-23764.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bloch-Michel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1987</year>
            <month>Feb</month>
            <day>15</day>
            <volume>103</volume>
            <issue>2</issue>
            <fpage>234</fpage>
            <page-range>234-5</page-range>
            <pub-id pub-id-type="pmid">3812627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <collab>Standardization of Uveitis Nomenclature (SUN) Working Group</collab>
            </person-group>
            <article-title>Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>140</volume>
            <issue>3</issue>
            <fpage>509</fpage>
            <page-range>509-16</page-range>
            <pub-id pub-id-type="pmid">16196117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agrawal</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sangwan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Current approach in diagnosis and management of anterior uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-9</page-range>
            <pub-id pub-id-type="pmid">20029142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Duplechain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Conrady</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Uveitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">31082037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harthan</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Opitz</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Fromstein</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Morettin</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of anterior uveitis: optometric management.</article-title>
            <source>Clin Optom (Auckl)</source>
            <year>2016</year>
            <volume>8</volume>
            <fpage>23</fpage>
            <page-range>23-35</page-range>
            <pub-id pub-id-type="pmid">30214346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wakefield</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Clarke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McCluskey</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Recent Developments in HLA B27 Anterior Uveitis.</article-title>
            <source>Front Immunol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>608134</fpage>
            <pub-id pub-id-type="pmid">33469457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kestelyn</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>An eye on inflammatory eye disease.</article-title>
            <source>Acta Clin Belg</source>
            <year>2005</year>
            <season>Sep-Oct</season>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>270</fpage>
            <page-range>270-5</page-range>
            <pub-id pub-id-type="pmid">16398326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biggioggero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Becciolini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miserocchi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Favalli</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future.</article-title>
            <source>Biomed Res Int</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9460187</fpage>
            <pub-id pub-id-type="pmid">30406148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallagher</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Juvenile rheumatoid arthritis.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>372</fpage>
            <page-range>372-6</page-range>
            <pub-id pub-id-type="pmid">10503657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ungaro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mehandru</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Peyrin-Biroulet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Colombel</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Ulcerative colitis.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Apr</month>
            <day>29</day>
            <volume>389</volume>
            <issue>10080</issue>
            <fpage>1756</fpage>
            <page-range>1756-1770</page-range>
            <pub-id pub-id-type="pmid">27914657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barth</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Segal</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Reactive arthritis (Reiter's syndrome).</article-title>
            <source>Am Fam Physician</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>60</volume>
            <issue>2</issue>
            <fpage>499</fpage>
            <page-range>499-503, 507</page-range>
            <pub-id pub-id-type="pmid">10465225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ungprasert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Matteson</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.</article-title>
            <source>Mayo Clin Proc Innov Qual Outcomes</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>358</fpage>
            <page-range>358-375</page-range>
            <pub-id pub-id-type="pmid">31485575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nair</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Moots</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Behcet's disease.</article-title>
            <source>Clin Med (Lond)</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-77</page-range>
            <pub-id pub-id-type="pmid">28148585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clive</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Vanguri</surname>
                <given-names>VK</given-names>
              </name>
            </person-group>
            <article-title>The Syndrome of Tubulointerstitial Nephritis With Uveitis (TINU).</article-title>
            <source>Am J Kidney Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>118</fpage>
            <page-range>118-128</page-range>
            <pub-id pub-id-type="pmid">29429748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fava</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Systemic lupus erythematosus: Diagnosis and clinical management.</article-title>
            <source>J Autoimmun</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>96</volume>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">30448290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghasemi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Razavi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nikzad</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.</article-title>
            <source>Cell J</source>
            <year>2017</year>
            <season>Apr-Jun</season>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">28367411</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Ankylosing spondylitis: etiology, pathogenesis, and treatments.</article-title>
            <source>Bone Res</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>22</fpage>
            <pub-id pub-id-type="pmid">31666997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Bloom</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Atun</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dye</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nardell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Salomon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vassall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Volchenkov</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Tuberculosis</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Holmes</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Bertozzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Jha</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <source>Major Infectious Diseases</source>
            <edition>3rd</edition>
            <publisher-name>The International Bank for Reconstruction and Development / The World Bank</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>2017</year>
            <month>11</month>
            <day>03</day>
            <pub-id pub-id-type="pmid">30212088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mohseni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takov</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <chapter-title>Chlamydia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30725971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biesiada</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Czepiel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Le&#x0015b;niak</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Garlicki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mach</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Lyme disease: review.</article-title>
            <source>Arch Med Sci</source>
            <year>2012</year>
            <month>Dec</month>
            <day>20</day>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>978</fpage>
            <page-range>978-82</page-range>
            <pub-id pub-id-type="pmid">23319969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Whitley</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex virus infection.</article-title>
            <source>Semin Pediatr Infect Dis</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-11</page-range>
            <pub-id pub-id-type="pmid">12118847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Halonen</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Toxoplasmosis.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>114</volume>
            <fpage>125</fpage>
            <page-range>125-45</page-range>
            <pub-id pub-id-type="pmid">23829904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Alvarez-Pasquin</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bijl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gaillat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clara</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Labetoulle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Michel</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Naldi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanmarti</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Weinke</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.</article-title>
            <source>Ther Adv Vaccines</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>109</fpage>
            <page-range>109-20</page-range>
            <pub-id pub-id-type="pmid">26478818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Engelhard</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Sim</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Medical Malpractice in Uveitis: A Review of Clinical Entities and Outcomes.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2018</year>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>242</fpage>
            <page-range>242-248</page-range>
            <pub-id pub-id-type="pmid">27715388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delwig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Keenan</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Margolis</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Topical Valganciclovir for the Treatment of Hypertensive Anterior Uveitis.</article-title>
            <source>Cornea</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>1513</fpage>
            <page-range>1513-5</page-range>
            <pub-id pub-id-type="pmid">26356754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moorthy</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>ET</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced uveitis.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>589</fpage>
            <page-range>589-97</page-range>
            <pub-id pub-id-type="pmid">24100371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kubicka-Trzaska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Romanowska-Dixon</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Malignant uveitis masquerade syndromes.</article-title>
            <source>Klin Oczna</source>
            <year>2008</year>
            <volume>110</volume>
            <issue>4-6</issue>
            <fpage>199</fpage>
            <page-range>199-202</page-range>
            <pub-id pub-id-type="pmid">18655462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cypel</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Zuker</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Juvenile xanthogranuloma: case report and review of the literature.</article-title>
            <source>Can J Plast Surg</source>
            <year>2008</year>
            <season>Fall</season>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-7</page-range>
            <pub-id pub-id-type="pmid">19721800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yeung</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Popp</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>The role of sex in uveitis and ocular inflammation.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2015</year>
            <season>Summer</season>
            <volume>55</volume>
            <issue>3</issue>
            <fpage>111</fpage>
            <page-range>111-31</page-range>
            <pub-id pub-id-type="pmid">26035764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>D'Ambrosio</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>La Cava</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tortorella</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gharbiya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campanella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iannetti</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical Features and Complications of the HLA-B27-associated Acute Anterior Uveitis: A Metanalysis.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2017</year>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>689</fpage>
            <page-range>689-701</page-range>
            <pub-id pub-id-type="pmid">27404944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calonge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pedroza-Seres</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Akova</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Messmer</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>D'Amico</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Referral patterns of uveitis in a tertiary eye care center.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1996</year>
            <month>May</month>
            <volume>114</volume>
            <issue>5</issue>
            <fpage>593</fpage>
            <page-range>593-9</page-range>
            <pub-id pub-id-type="pmid">8619771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Ankylosing spondylitis, Reiter's syndrome, psoriatic arthritis, and arthritis of inflammatory bowel disease.</article-title>
            <source>Prim Care</source>
            <year>1984</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>271</fpage>
            <page-range>271-82</page-range>
            <pub-id pub-id-type="pmid">6332327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sen</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ucar</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Gender disparities in ocular inflammatory disorders.</article-title>
            <source>Curr Eye Res</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>146</fpage>
            <page-range>146-61</page-range>
            <pub-id pub-id-type="pmid">24987987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DARRELL</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>WAGENER</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>KURLAND</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of uveitis. Incidence and prevalence in a small urban community.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1962</year>
            <month>Oct</month>
            <volume>68</volume>
            <fpage>502</fpage>
            <page-range>502-14</page-range>
            <pub-id pub-id-type="pmid">13883604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gritz</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>IG</given-names>
              </name>
            </person-group>
            <article-title>Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study.</article-title>
            <source>Ophthalmology</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>491</fpage>
            <page-range>491-500; discussion 500</page-range>
            <pub-id pub-id-type="pmid">15019324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suhler</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Lloyd</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>146</volume>
            <issue>6</issue>
            <fpage>890</fpage>
            <page-range>890-6.e8</page-range>
            <pub-id pub-id-type="pmid">19027424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reeves</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Sloan</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort.</article-title>
            <source>Ophthalmology</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>113</volume>
            <issue>2</issue>
            <fpage>307.e1</fpage>
            <pub-id pub-id-type="pmid">16406541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Digre</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Brennan</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Shedding light on photophobia.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-81</page-range>
            <pub-id pub-id-type="pmid">22330853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balamurugan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hasanreisoglu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toy</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Akhter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anuradha</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Anthony</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Interleukins and cytokine biomarkers in uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>9</issue>
            <fpage>1750</fpage>
            <page-range>1750-1763</page-range>
            <pub-id pub-id-type="pmid">32823391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akinsoji</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Goldhardt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Galor</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A Glimpse into Uveitis in the Aging Eye: Pathophysiology, Clinical Presentation and Treatment Considerations.</article-title>
            <source>Drugs Aging</source>
            <year>2018</year>
            <month>May</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>399</fpage>
            <page-range>399-408</page-range>
            <pub-id pub-id-type="pmid">29663152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yanai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sonoda</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>[Pathophysiology and new treatment of uveitis].</article-title>
            <source>Nihon Rinsho Meneki Gakkai Kaishi</source>
            <year>2014</year>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>74</fpage>
            <page-range>74-82</page-range>
            <pub-id pub-id-type="pmid">24835134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pritt</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Histopathologic review of granulomatous inflammation.</article-title>
            <source>J Clin Tuberc Other Mycobact Dis</source>
            <year>2017</year>
            <month>May</month>
            <volume>7</volume>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">31723695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sayg&#x00131;n</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Lowder</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maya</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Hajj-Ali</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of inflammatory eye disease associated with hidradenitis suppurativa.</article-title>
            <source>Eur J Rheumatol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>165</fpage>
            <page-range>165-168</page-range>
            <pub-id pub-id-type="pmid">30071934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e9;rida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Palacios</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Navea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bosch-Morell</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Macrophages and Uveitis in Experimental Animal Models.</article-title>
            <source>Mediators Inflamm</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>671417</fpage>
            <pub-id pub-id-type="pmid">26078494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joltikov</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Lobo-Chan</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2021</year>
            <volume>8</volume>
            <fpage>695904</fpage>
            <pub-id pub-id-type="pmid">34568364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phillips</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Posterior synechiae after glaucoma operations: aggravation by shallow anterior chamber and pilocarpine.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>428</fpage>
            <page-range>428-32</page-range>
            <pub-id pub-id-type="pmid">3620422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nche</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Amer</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Lens-induced uveitis: an update.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>258</volume>
            <issue>7</issue>
            <fpage>1359</fpage>
            <page-range>1359-1365</page-range>
            <pub-id pub-id-type="pmid">31907641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakunowicz-Lazarczyk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Proniewska-Skretek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Walkowiak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grochowski</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Parasitic uveitis in children].</article-title>
            <source>Klin Oczna</source>
            <year>1992</year>
            <volume>94</volume>
            <issue>2-3</issue>
            <fpage>46</fpage>
            <pub-id pub-id-type="pmid">1640677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Read</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Zamir</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Neoplastic masquerade syndromes.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2002</year>
            <season>Mar-Apr</season>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-124</page-range>
            <pub-id pub-id-type="pmid">11918892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrahams</surname>
                <given-names>IW</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and surgical management of phacoanaphylactic uveitis following extracapsular cataract extraction with intraocular lens implantation.</article-title>
            <source>J Am Intraocul Implant Soc</source>
            <year>1985</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>444</fpage>
            <page-range>444-7</page-range>
            <pub-id pub-id-type="pmid">4044382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Perez</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Cruz-Alamo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Perez-Aciego</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mac&#x000ed;a-Heras</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Naranjo-Hernandez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plaza-Toledano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hortal-Cascon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fernandez-Rodriguez</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical and immune aspects of idiopathic acute tubulointerstitial nephritis and uveitis syndrome.</article-title>
            <source>Am J Nephrol</source>
            <year>1995</year>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>386</fpage>
            <page-range>386-91</page-range>
            <pub-id pub-id-type="pmid">7503137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ormerod</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Puklin</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Giles</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Chronic Propionibacterium acnes endophthalmitis as a cause of intermediate uveitis.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <page-range>67-8</page-range>
            <pub-id pub-id-type="pmid">9145695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r53">
          <label>53</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gurnani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Endogenous Endophthalmitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>11</day>
            <pub-id pub-id-type="pmid">35015416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwock</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Geddie</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of B-cell non-hodgkin lymphomas with small-/intermediate-sized cells in cytopathology.</article-title>
            <source>Patholog Res Int</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>164934</fpage>
            <pub-id pub-id-type="pmid">22693682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>YF</given-names>
              </name>
            </person-group>
            <article-title>Effect of primary iris and ciliary body cyst on anterior chamber angle in patients with shallow anterior chamber.</article-title>
            <source>J Zhejiang Univ Sci B</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>9</issue>
            <fpage>723</fpage>
            <page-range>723-30</page-range>
            <pub-id pub-id-type="pmid">22949363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozdal</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Berker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tugal-Tutkun</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2015</year>
            <season>Oct-Dec</season>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>469</fpage>
            <page-range>469-80</page-range>
            <pub-id pub-id-type="pmid">27051493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sudharshan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ganesh</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Current approach in the diagnosis and management of posterior uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>58</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-43</page-range>
            <pub-id pub-id-type="pmid">20029144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coburn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Jewett</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Kraiczy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Skare</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lyme Disease Pathogenesis.</article-title>
            <source>Curr Issues Mol Biol</source>
            <year>2021</year>
            <volume>42</volume>
            <fpage>473</fpage>
            <page-range>473-518</page-range>
            <pub-id pub-id-type="pmid">33353871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deschenes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <collab>International Uveitis Study Group</collab>
            </person-group>
            <article-title>International Uveitis Study Group (IUSG): clinical classification of uveitis.</article-title>
            <source>Ocul Immunol Inflamm</source>
            <year>2008</year>
            <season>Jan-Feb</season>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-2</page-range>
            <pub-id pub-id-type="pmid">18379933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trusko</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Belfort</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gangaputra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>J</given-names>
              </name>
              <collab>Standardization of Uveitis Nomenclature (SUN) Project</collab>
            </person-group>
            <article-title>The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques.</article-title>
            <source>Methods Inf Med</source>
            <year>2013</year>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>259</fpage>
            <page-range>259-65, S1-6</page-range>
            <pub-id pub-id-type="pmid">23392263</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Busingye</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Approach to the diagnosis of the uveitides.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>156</volume>
            <issue>2</issue>
            <fpage>228</fpage>
            <page-range>228-36</page-range>
            <pub-id pub-id-type="pmid">23668682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Micieli</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Margolin</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A 30-year-old woman with vision loss and painful eye movements.</article-title>
            <source>CMAJ</source>
            <year>2015</year>
            <month>Jun</month>
            <day>16</day>
            <volume>187</volume>
            <issue>9</issue>
            <fpage>673</fpage>
            <page-range>673-675</page-range>
            <pub-id pub-id-type="pmid">25869872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oshika</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mochizuki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iwase</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sawa</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Quantitative assessment of aqueous flare and cells in uveitis.</article-title>
            <source>Jpn J Ophthalmol</source>
            <year>1989</year>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>279</fpage>
            <page-range>279-87</page-range>
            <pub-id pub-id-type="pmid">2796009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaidi</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gangaputra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Suhler</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Levy-Clarke</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Nussenblatt</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kempen</surname>
                <given-names>JH</given-names>
              </name>
              <collab>Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study</collab>
            </person-group>
            <article-title>Hypopyon in patients with uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>117</volume>
            <issue>2</issue>
            <fpage>366</fpage>
            <page-range>366-72</page-range>
            <pub-id pub-id-type="pmid">20006905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pujari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Urkude</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Child with hypopyon.</article-title>
            <source>BMJ Case Rep</source>
            <year>2017</year>
            <month>Oct</month>
            <day>20</day>
            <volume>2017</volume>
            <pub-id pub-id-type="pmid">29054898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pillai</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Dua</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Azuara-Blanco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sarhan</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of corneal endothelium and keratic precipitates by specular microscopy in anterior uveitis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>84</volume>
            <issue>12</issue>
            <fpage>1367</fpage>
            <page-range>1367-71</page-range>
            <pub-id pub-id-type="pmid">11090474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van der Lelij</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ooijman</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Kijlstra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases.</article-title>
            <source>Ophthalmology</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>107</volume>
            <issue>6</issue>
            <fpage>1164</fpage>
            <page-range>1164-70</page-range>
            <pub-id pub-id-type="pmid">10857838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lauer</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Rosenbaum</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Iris nodules associated with infectious uveitis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>86</volume>
            <issue>9</issue>
            <fpage>969</fpage>
            <page-range>969-74</page-range>
            <pub-id pub-id-type="pmid">12185117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Messina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elalfy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fares</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ghoz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mavi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dua</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Creeping posterior synechiae following hyperopic iris-fixated phakic implants.</article-title>
            <source>Int Ophthalmol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>901</fpage>
            <page-range>901-905</page-range>
            <pub-id pub-id-type="pmid">26909500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stelzer</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>[Iris heterochromia: variations in form, age changes, sex dimorphism].</article-title>
            <source>Anthropol Anz</source>
            <year>1979</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-16</page-range>
            <pub-id pub-id-type="pmid">485098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cern&#x000e1;k</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Markovic</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cern&#x000e1;k</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[The treatment of the rubeosis of the iris and the neovascular glaucoma in proliferative diabetic retinopathy by means of anti-VEGF].</article-title>
            <source>Cesk Slov Oftalmol</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>234</fpage>
            <page-range>234-6</page-range>
            <pub-id pub-id-type="pmid">19110964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkhayyal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>DU</given-names>
              </name>
            </person-group>
            <article-title>Practice patterns for herpes simplex keratitis: A survey of ophthalmologists in Gulf Coast countries.</article-title>
            <source>Saudi J Ophthalmol</source>
            <year>2017</year>
            <season>Apr-Jun</season>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>61</fpage>
            <page-range>61-64</page-range>
            <pub-id pub-id-type="pmid">28559714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Sumsion</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gorchynski</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Don't Forget What You Can't See: A Case of Ocular Syphilis.</article-title>
            <source>West J Emerg Med</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>473</fpage>
            <page-range>473-6</page-range>
            <pub-id pub-id-type="pmid">27429702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kujundzi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].</article-title>
            <source>Acta Med Croatica</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-201</page-range>
            <pub-id pub-id-type="pmid">24471303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adio</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Alikor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Awoyesuku</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Survey of pediatric ophthalmic diagnoses in a teaching hospital in Nigeria.</article-title>
            <source>Niger J Med</source>
            <year>2011</year>
            <season>Jan-Mar</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-8</page-range>
            <pub-id pub-id-type="pmid">21970270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Majumder</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Sudharshan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Laboratory support in the diagnosis of uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>269</fpage>
            <page-range>269-76</page-range>
            <pub-id pub-id-type="pmid">23803478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lardenoye</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>van Kooij</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Impact of macular edema on visual acuity in uveitis.</article-title>
            <source>Ophthalmology</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>113</volume>
            <issue>8</issue>
            <fpage>1446</fpage>
            <page-range>1446-9</page-range>
            <pub-id pub-id-type="pmid">16877081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baneke</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Stanford</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The Pathogenesis of Raised Intraocular Pressure in Uveitis.</article-title>
            <source>Curr Eye Res</source>
            <year>2016</year>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-49</page-range>
            <pub-id pub-id-type="pmid">25974243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rathinam</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Babu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Algorithmic approach in the diagnosis of uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>255</fpage>
            <page-range>255-62</page-range>
            <pub-id pub-id-type="pmid">23803476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yemm</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Pecen</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Fliney</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Palestine</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Chest X-ray and Uveitis Evaluation in a Population with Low Incidence of Sarcoidosis.</article-title>
            <source>Ophthalmol Ther</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-584</page-range>
            <pub-id pub-id-type="pmid">32613593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dess&#x000ec;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lahuerta</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Puce</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Mendoza</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Stefanini</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Del Prato</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Perinetti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Role of B-scan ocular ultrasound as an adjuvant for the clinical assessment of eyeball diseases: a pictorial essay.</article-title>
            <source>J Ultrasound</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>265</fpage>
            <page-range>265-77</page-range>
            <pub-id pub-id-type="pmid">26261467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Regatieri</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Alwassia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Vora</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Use of optical coherence tomography in the diagnosis and management of uveitis.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2012</year>
            <season>Fall</season>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>33</fpage>
            <page-range>33-43</page-range>
            <pub-id pub-id-type="pmid">22954927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Fluorescein and indocyanine green angiography for uveitis.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>168</fpage>
            <page-range>168-87</page-range>
            <pub-id pub-id-type="pmid">20404985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agrawal</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gunasekaran</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography in posterior uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>148</fpage>
            <page-range>148-59</page-range>
            <pub-id pub-id-type="pmid">23685486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marchese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moretti</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Handa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Modorati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Querques</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bandello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Miserocchi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Advances in imaging of uveitis.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2020</year>
            <season>Jan-Dec</season>
            <volume>12</volume>
            <fpage>2515841420917781</fpage>
            <pub-id pub-id-type="pmid">32524072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vojvodi&#x00107;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ademovi&#x00107;-Sazdani&#x00107;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Busar&#x0010d;evi&#x00107;</surname>
              </name>
            </person-group>
            <article-title>Human leukocyte antigen-b27 and disease susceptibility in vojvodina, serbia.</article-title>
            <source>Balkan J Med Genet</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>55</fpage>
            <page-range>55-60</page-range>
            <pub-id pub-id-type="pmid">24052732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Marfatia</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Serological tests for syphilis.</article-title>
            <source>Indian J Sex Transm Dis AIDS</source>
            <year>2019</year>
            <season>Jul-Dec</season>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>186</fpage>
            <page-range>186-191</page-range>
            <pub-id pub-id-type="pmid">31922115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinreb</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Sandman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Char</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Angiotensin-converting enzyme in sarcoid uveitis.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>1979</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>12</issue>
            <fpage>1285</fpage>
            <page-range>1285-7</page-range>
            <pub-id pub-id-type="pmid">229083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrison</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Erythrocyte sedimentation rate and C-reactive protein.</article-title>
            <source>Aust Prescr</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>93</fpage>
            <page-range>93-4</page-range>
            <pub-id pub-id-type="pmid">26648629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schriefer</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Lyme Disease Diagnosis: Serology.</article-title>
            <source>Clin Lab Med</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>797</fpage>
            <page-range>797-814</page-range>
            <pub-id pub-id-type="pmid">26593258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasap&#x000e7;opur</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yologlu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ozyazgan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ercan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caliskan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sever</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ozdogan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arisoy</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis.</article-title>
            <source>Indian Pediatr</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>1035</fpage>
            <page-range>1035-9</page-range>
            <pub-id pub-id-type="pmid">15523130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hagen</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>van de Vijver-Reenalda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Keizer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kijlstra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Es</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Daha</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>van der Woude</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Uveitis and anti-neutrophil cytoplasmic antibodies.</article-title>
            <source>Clin Exp Immunol</source>
            <year>1994</year>
            <month>Jan</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-9</page-range>
            <pub-id pub-id-type="pmid">8287609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ngan</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chee</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis.</article-title>
            <source>Eye (Lond)</source>
            <year>2012</year>
            <month>May</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>658</fpage>
            <page-range>658-65</page-range>
            <pub-id pub-id-type="pmid">22302066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Clinical manifestations and treatment outcomes of syphilitic uveitis in HIV-negative patients in China: A retrospective case study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>96</volume>
            <issue>43</issue>
            <fpage>e8376</fpage>
            <pub-id pub-id-type="pmid">29069031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allegri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rissotto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Murialdo</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>CNS diseases and uveitis.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>284</fpage>
            <page-range>284-308</page-range>
            <pub-id pub-id-type="pmid">22454751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patnaik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Annamalai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Intraocular biopsy in uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>9</issue>
            <fpage>1838</fpage>
            <page-range>1838-1843</page-range>
            <pub-id pub-id-type="pmid">32823400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Damato</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Angi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Semeraro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Costagliola</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Vitreous analysis in the management of uveitis.</article-title>
            <source>Mediators Inflamm</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>863418</fpage>
            <pub-id pub-id-type="pmid">23150722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Annamalai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Krishnaraj</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Biopsy pathology in uveitis.</article-title>
            <source>Middle East Afr J Ophthalmol</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>261</fpage>
            <page-range>261-7</page-range>
            <pub-id pub-id-type="pmid">22224013</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doycheva</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Deuter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grajewski</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>[Topical Corticosteroids and Non-steroidal Anti-inflammatory Drugs in the Therapy of Non-infectious Uveitis].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>2018</year>
            <month>May</month>
            <volume>235</volume>
            <issue>5</issue>
            <fpage>586</fpage>
            <page-range>586-591</page-range>
            <pub-id pub-id-type="pmid">29739028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Pavesio</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A simple technique to administer mydricaine in needle-phobic patients.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>418</fpage>
            <pub-id pub-id-type="pmid">19244033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lerner</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kenney</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Minckler</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Use of intraocular human recombinant tissue plasminogen activator as an adjunct treatment of posterior synechiae in patients with uveitis.</article-title>
            <source>Retin Cases Brief Rep</source>
            <year>2012</year>
            <season>Summer</season>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>290</fpage>
            <page-range>290-3</page-range>
            <pub-id pub-id-type="pmid">25389735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Babu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mahendradas</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Medical management of uveitis - current trends.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>277</fpage>
            <page-range>277-83</page-range>
            <pub-id pub-id-type="pmid">23803479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lafranco Dafflon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Guex-Crosier</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Herbort</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1999</year>
            <month>Apr</month>
            <volume>237</volume>
            <issue>4</issue>
            <fpage>289</fpage>
            <page-range>289-95</page-range>
            <pub-id pub-id-type="pmid">10208261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Degenring</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>361</fpage>
            <pub-id pub-id-type="pmid">12598455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Antimetabolite Therapy for Uveitis: Methotrexate or Mycophenolate?</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2019</year>
            <month>Dec</month>
            <day>01</day>
            <volume>137</volume>
            <issue>12</issue>
            <fpage>1449</fpage>
            <page-range>1449-1451</page-range>
            <pub-id pub-id-type="pmid">31503274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis.</article-title>
            <source>J Korean Med Sci</source>
            <year>2019</year>
            <month>Nov</month>
            <day>04</day>
            <volume>34</volume>
            <issue>42</issue>
            <fpage>e278</fpage>
            <pub-id pub-id-type="pmid">31674159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Laar</surname>
                <given-names>JAM</given-names>
              </name>
              <name>
                <surname>Rothova</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Missotten</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kuijpers</surname>
                <given-names>RWAM</given-names>
              </name>
              <name>
                <surname>van Hagen</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>van Velthoven</surname>
                <given-names>MEJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of uveitis; not restricted to the ophthalmologist.</article-title>
            <source>J Clin Transl Res</source>
            <year>2015</year>
            <month>Sep</month>
            <day>30</day>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-99</page-range>
            <pub-id pub-id-type="pmid">30873449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r108">
          <label>108</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Edelsten</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The risk of complications of uveitis in a district hospital cohort.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>88</volume>
            <issue>4</issue>
            <fpage>512</fpage>
            <page-range>512-7</page-range>
            <pub-id pub-id-type="pmid">15031168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murthy</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Pappuru</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Latha</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kamat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sangwan</surname>
                <given-names>VS</given-names>
              </name>
            </person-group>
            <article-title>Surgical management in patient with uveitis.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <fpage>284</fpage>
            <page-range>284-90</page-range>
            <pub-id pub-id-type="pmid">23803480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCluskey</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Towler</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of chronic uveitis.</article-title>
            <source>BMJ</source>
            <year>2000</year>
            <month>Feb</month>
            <day>26</day>
            <volume>320</volume>
            <issue>7234</issue>
            <fpage>555</fpage>
            <page-range>555-8</page-range>
            <pub-id pub-id-type="pmid">10688564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23764.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Engelhard</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Patrie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Prenshaw</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bajwa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Monahan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Traumatic uveitis in the mid-Atlantic United States.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2015</year>
            <volume>9</volume>
            <fpage>1869</fpage>
            <page-range>1869-74</page-range>
            <pub-id pub-id-type="pmid">26491249</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
